Company · AI

Maxwell Plus

Machine-vision-powered clinician support system for prostate cancer detection, later pivoted to direct-to-consumer healthcare

Investor	Rounds	Invested
No investors recorded yet. Know one?

What Maxwell Plus bought

Companies Maxwell Plus acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Maxwell Plus is not recorded as having acquired anything.

Name	Role	Sources
Dr Elliot Smith	CEO (former) · Founder	Startup Daily, Main Sequence

Coverage

Stories naming Maxwell Plus. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $158m

The founder of one of Main Sequence’s first investments, medtech Maxwell Plus, on failure, timing, and being ahead of the pack

A retrospective on Maxwell Plus, a machine-vision prostate cancer medtech that folded, with founder Elliot Smith and investor Phil Morle sharing lessons; Harrison.ai's later raise underscores the timing they missed.

Startup Daily 8 Dec 2024 CSIRO Harrison AI Main Sequence Ventures Maxwell Plus Dr Elliot Smith Phil Morle

Also Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Forbes Australia·Forbes Australia

Funding announcement

Maxwell Plus - Lessons Learned

Main Sequence reflects on Maxwell Plus, an early machine-vision healthcare bet it made in 2017 and later wound up, with founder and investor each sharing candid go-to-market and hiring lessons from the failure.

Main Sequence Ventures portfolio 4 Dec 2024 Google Main Sequence Ventures Maxwell Plus Dr Elliot Smith

Also Startup Daily

Something wrong? Tell us

Maxwell Plus

Funding history

Investors

What Maxwell Plus bought

People

Coverage

The founder of one of Main Sequence’s first investments, medtech Maxwell Plus, on failure, timing, and being ahead of the pack

Maxwell Plus - Lessons Learned